<DOC>
	<DOC>NCT00486083</DOC>
	<brief_summary>The purpose of the study is to compare atomoxetine hydrochloride and methylphenidate hydrochloride in pediatric patients with ADHD.</brief_summary>
	<brief_title>Comparison Atomoxetine Hydrochloride and Comparator in Pediatric Outpatients With ADHD</brief_title>
	<detailed_description />
	<mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Be at least 6 years of age and not more than 16 years of age at Visit 1 Must meet DSMIV criteria for ADHD Must be of normal intelligence (that is, without a general impairment of intelligence and likely, in the investigator's judgement, to achieve a score of greater than or equal to 70 on an IQ test) Must be able to swallow capsules Must have laboratory results that show no significant abnormalities (significant would include laboratory deviations requiring acute medical intervention or further medical evaluation) Weigh less than 20 kg or more than 60 kg at study entry Have a history of Bipolar I or II disorder, psychosis, or pervasive developmental disorder Meet DSMIV criteria for an anxiety disorder Have a history of any seizure disorder (other than febrile seizures)or prior ECG abnormalities related to epilepsy, or subjects who have taken or are currently taking anticonvulsants for seizure control Have a history of severe allergies to more than 1 class of medications or multiple adverse drug reactions,including a hypersensitivity to methylphenidate</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>June 2007</verification_date>
</DOC>